Pembrolizumab outperforms tyrosine kinase inhibitors as adjuvant treatment in patients with high-risk renal cell carcinoma after nephrectomy

Adjuvant Treatment ◽

Renal Cell ◽

Kinase Inhibitors

The merit of tyrosine kinase inhibitors in the adjuvant setting of high-risk renal cell carcinoma: a meta-analysis

Future Oncology ◽

10.2217/fon-2017-0333 ◽

2018 ◽

Vol 14 (9) ◽

pp. 829-835 ◽

Cited By ~ 4

Author(s):

Hampig Raphael Kourie ◽

Ziad Bakouny ◽

Roland Eid ◽

Fady GH Haddad ◽

Joseph Kattan

Keyword(s):

Renal Cell Carcinoma ◽

High Risk ◽

Tyrosine Kinase ◽

Cell Carcinoma ◽

Renal Cell ◽

Kinase Inhibitors ◽

Meta Analysis ◽

Adjuvant Setting

Adjuvant immunotherapy versus tyrosine kinase inhibitors in patients with high-risk renal cell carcinoma: A systematic review and network meta-analysis of oncologic and toxicity outcomes

European Urology Open Science ◽

10.1016/s2666-1683(21)03169-4 ◽

2021 ◽

Vol 33 ◽

pp. S333-S334

Author(s):

E. Laukhtina ◽

F. Quhal ◽

K. Mori ◽

R. Sari Motlagh ◽

S. Katayama ◽

...

Keyword(s):

Systematic Review ◽

Renal Cell Carcinoma ◽

High Risk ◽

Tyrosine Kinase ◽

Cell Carcinoma ◽

Renal Cell ◽

Kinase Inhibitors ◽

Meta Analysis ◽

Adjuvant Immunotherapy

Antiangiogenic tyrosine kinase inhibitors and immunotherapy as first-line treatment for metastatic renal cell carcinoma: is there an increased risk of hypothyroidism?

Therapeutic Advances in Urology ◽

10.1177/17562872211029784 ◽

2021 ◽

Vol 13 ◽

pp. 175628722110297

Author(s):

Giandomenico Roviello ◽

Sebastiano Buti ◽

Carlo Cattrini ◽

Alessia Mennitto ◽

Carlo Messina ◽

...

Keyword(s):

Renal Cell Carcinoma ◽

Tyrosine Kinase ◽

Cell Carcinoma ◽

Renal Cell ◽

Kinase Inhibitors ◽

Line Treatment ◽

First Line ◽

Increased Risk ◽

First Line Treatment

Prognostic biomarkers for patients with advanced renal cell carcinoma treated with VEGF-targeted tyrosine kinase inhibitors

OncoTargets and Therapy ◽

10.2147/ott.s45872 ◽

2013 ◽

pp. 679 ◽

Cited By ~ 1

Author(s):

Daniel Cho

Keyword(s):

Renal Cell Carcinoma ◽

Tyrosine Kinase ◽

Cell Carcinoma ◽

Renal Cell ◽

Kinase Inhibitors ◽

Prognostic Biomarkers ◽

Advanced Renal Cell Carcinoma

Can Tyrosine Kinase Inhibitors be Discontinued in Patients with Metastatic Renal Cell Carcinoma and a Complete Response to Treatment? A Multicentre, Retrospective Analysis

European Urology ◽

10.1016/j.eururo.2008.10.021 ◽

2009 ◽

Vol 55 (6) ◽

pp. 1430-1439 ◽

Cited By ~ 69

Author(s):

Manfred Johannsen ◽

Anne Flörcken ◽

Axel Bex ◽

Jan Roigas ◽

Marco Cosentino ◽

...

Keyword(s):

Renal Cell Carcinoma ◽

Tyrosine Kinase ◽

Cell Carcinoma ◽

Retrospective Analysis ◽

Renal Cell ◽

Kinase Inhibitors ◽

Complete Response ◽

Response To Treatment

Acquired Hypothyroidism as a Predictive Marker of Outcome in Patients With Metastatic Renal Cell Carcinoma Treated With Tyrosine Kinase Inhibitors: A Literature-Based Meta-Analysis

Clinical Genitourinary Cancer ◽

10.1016/j.clgc.2014.10.002 ◽

2015 ◽

Vol 13 (4) ◽

pp. 280-286 ◽

Cited By ~ 13

Author(s):

Andreas Nearchou ◽

Antonis Valachis ◽

Pehr Lind ◽

Olof Akre ◽

Per Sandström

Keyword(s):

Renal Cell Carcinoma ◽

Tyrosine Kinase ◽

Cell Carcinoma ◽

Renal Cell ◽

Kinase Inhibitors ◽

Meta Analysis ◽

Predictive Marker

Additional Tyrosine Kinase Inhibitors in Renal Cell Carcinoma

Renal Cell Carcinoma ◽

10.1007/978-1-59745-332-5_10 ◽

2009 ◽

pp. 189-193

Author(s):

Brian I. Rini

Keyword(s):

Renal Cell Carcinoma ◽

Tyrosine Kinase ◽

Cell Carcinoma ◽

Renal Cell ◽

Kinase Inhibitors

PD57-08 TUMORAL CD8+ T CELLS CORRELATE WITH FAVORABLE OUTCOME IN METASTATIC RENAL CELL CARCINOMA TREATED WITH TYROSINE KINASE INHIBITORS

The Journal of Urology ◽

10.1016/j.juro.2018.02.2652 ◽

2018 ◽

Vol 199 (4S) ◽

Author(s):

Jiajun Wang ◽

Li Liu ◽

Wei Xi ◽

Jiejie Xu ◽

Jianming Guo

Keyword(s):

Renal Cell Carcinoma ◽

T Cells ◽

Tyrosine Kinase ◽

Cell Carcinoma ◽

Cd8 T Cells ◽

Renal Cell ◽

Kinase Inhibitors ◽

Favorable Outcome

Tumor-infiltrating neutrophils predict therapeutic benefit of tyrosine kinase inhibitors in metastatic renal cell carcinoma

OncoImmunology ◽

10.1080/2162402x.2018.1515611 ◽

2018 ◽

Vol 8 (1) ◽

pp. e1515611

Author(s):

Jiajun Wang ◽

Li Liu ◽

Qi Bai ◽

Chenzhang Ou ◽

Ying Xiong ◽

...

Keyword(s):

Renal Cell Carcinoma ◽

Tyrosine Kinase ◽

Cell Carcinoma ◽

Renal Cell ◽

Kinase Inhibitors ◽

Therapeutic Benefit

Second-Generation Tyrosine Kinase Inhibitors (Pazopanib) in Renal Cell Carcinoma: Current Status

Renal Cell Carcinoma ◽

10.1007/978-1-4939-1622-1_9 ◽

2014 ◽

pp. 207-216

Author(s):

Linda Cerbone ◽

Cora N. Sternberg

Keyword(s):

Renal Cell Carcinoma ◽

Tyrosine Kinase ◽

Cell Carcinoma ◽

Renal Cell ◽

Second Generation ◽

Kinase Inhibitors ◽

Current Status